BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
IFM Therapeutics (1) is defunct.

Fate: Acquired by BMS after less than a year, $300M + $1B milestones. Spinning out some assets into new company with same name


------------------
If you believe any of this information is incorrect, please let us know.